3TC300mg+TDF300mg tabs/PAC-30 No CTN

General Description:
Lamivudine 300mg + Tenofovir Disoproxil Fumarate 300mg, equivalent to245mg of Tenofovir Disoproxil, film coated tablets, in a bottle pack of 30 without outer carton.

Technical Specifications:
Each film coated tablet contains Lamivudine 300mg and Tenofovir Disoproxil fumarate 300mg which is equivalent to 245mg of Tenofovir Disoproxil.

Therapeutic class:
Lamivudine is a Nucleoside Reverse Transcriptase Inhibitor (NRTI)
Tenofovir is a Nucleotide Reverse Transcriptase Inhibitor (NtRTI)

Dosage, Instructions for use:
Please refer to the guideline WHO Model Formulary 2008: https://www.who.int/selection_medicines/list/WMF2008.pdf
For more details, please see WHO treatment guidelines www.who.int/hiv/pub/guidelines/en/index.html and WHO Essential Medicines Library www.who.int/emlib/ or your regional/national guidelines.

Details about paediatric dosage schemes can be found at http://www.who.int/hiv/topics/paediatric/en/index.html

WHO generic tool for assessing paediatric ARV dosing
http://www.who.int/hiv/paediatric/generictool/en/

Shelf life:
24 months

Storage conditions:
Do not store above 30°C

Alternative products:
S1400649 - 3TC30mg+AZT60mg disp. tabs/PAC-60 gb